Graeme Bell

Graeme Bell

No más puestos en curso
59 años
Health Technology
Finance
Technology Services

Perfil

Graeme Bell is the founder of Valuecycle LLC.
Mr. Bell is currently an Independent Director at Averin Capital Acquisition Corp.
since 2026, a Director at Cytoimmune Therapeutics, Inc. since 2023, a Director at Mindstate Design Labs, Inc. since 2025, and Group Chief Financial Officer at Owkin, Inc. since 2025.
Formerly, Mr. Bell was CEO, Chief Financial & People Officer at Valo Health, Inc. and Valo Health LLC from 2020 to 2024, Director-Investor Relations at Merck & Co., Inc. from 2007 to 2009, Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals LLC from 2015 to 2016, CFO, Principal Accounting Officer & Executive VP at Intellia Therapeutics, Inc. from 2016 to 2018, Chief Financial Officer at Tmunity Therapeutics, Inc. from 2018 to 2020, Director-Claims Development at Uris Group Ltd., and Head-Finance at Organon Pharma (UK) Ltd. Education includes an MBA from the University of Durham.

Cargos activos de Graeme Bell

EmpresasCargoInicio
Director/Miembro de la Junta 01/03/2023
Director Financiero/CFO 01/05/2025
Director/Miembro de la Junta 01/12/2025

Antiguos cargos conocidos de Graeme Bell.

EmpresasCargoFin
Director Ejecutivo 18/11/2024
Director Ejecutivo 18/11/2024
Director Financiero/CFO 01/06/2020
INTELLIA THERAPEUTICS, INC. Director Financiero/CFO 03/08/2018
ANACOR PHARMACEUTICALS INC Director Financiero/CFO 01/11/2016
Ver el detalle de la experiencia de Graeme Bell.

Formación de Graeme Bell.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

66

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

Technology Services

Health Technology

Health Technology